The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma
Abstract Renal cell carcinoma (RCC), a therapeutically recalcitrant genitourinary malignancy, exemplifies the profound interplay between oncogenic signaling and metabolic adaptation. Emerging evidence positions metabolic reprogramming as a central axis of RCC pathogenesis, characterized by dynamic s...
Saved in:
| Main Authors: | Yifan Zhang, Shengli Zhang, Hongbin Sun, Luwei Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02479-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications
by: Bocheng Gao, et al.
Published: (2025-04-01) -
Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance
by: Xiao Zheng, et al.
Published: (2025-05-01) -
Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives
by: Yan Zhang, et al.
Published: (2025-06-01) -
Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications
by: Jun Zhu, et al.
Published: (2025-08-01) -
Metabolic reprogramming in cancer: Mechanisms and therapeutics
by: Shiqi Nong, et al.
Published: (2023-04-01)